INNO-BIA AlzBio3
Choose high performance and ease of use. This multiparameter immunoassay allows the simultaneous quantification of Aß1-42, total tau, and P-tau181P in CSF using xMAP® technology*.
*xMAP is a registered trademark of Luminex Corp.
Article number: 80584 (96T), 80585 (8V)
Choose high performance and ease of use. This multiparameter assay allows the simultaneous quantification of Aß1-42, total tau, and P-tau181P in CSF using xMAP® technology*.
Disclaimer
A license regarding Amyloid beta antibodies contained in this product under patents US 570349 and EP 0683234 has been obtained from Takeda Pharmaceutical Company Limited.
Furthermore, a license for the use of Amyloid beta monoclonal antibodies contained in this product under patents US 5,593,846A, US 5,766,846A, US 5,837,672A, US 6,284,221B1, US 6,610,493B1, US 5,441,870A, US 5,721,130A, US 5,605,811A and US 6,114,133A has been obtained from Eli Lilly and Company.
Features & Benefits
- User-friendly bead-based immunoassay
High performance:
- Low intra- and inter-assay variation even at low concentrations
- High reproducibility
- Broad dynamic range
Ease of use:
- Only one test procedure
- Six ready-to-use (multiparametric) standards
- Inclusion of 2 run-validation control samples
- Limited number of handling steps
- Reduced hands-on time
- Sample: undiluted (75 µL) per well. Duplicate testing is strongly recommended and requires 2 x 75 µL CSF
Click
INNO-BIA AlzBio3 to view the commercial brochure.
Customer support
For all inquiries regarding Innogenetics products and instrumentation, we offer the services of our customer support team. This team of technical experts is committed to dealing with
-
General inquiries
-
Technical assistance
-
Complaint resolution
The customer support team is designed to be your principle point of contact. They will ensure that the appropriate person handles all product-related inquiries. For this service please contact us via e-mail, call us (+32-9 329 16 11), or fax (+32-9 329 17 75).